Inspiration Healthcare Group, a specialist in neonatal intensive care medical devices, has appointed Alan Olby ACA as Chief Financial Officer and Company Director.
Olbi is an experienced and commercially focused healthcare CFO with extensive international and operational experience within fast growing listed and private healthcare companies. He spent 16 years at Sinclair Pharma, of which 12 years as CFO and a member of the executive leadership team, and was instrumental in turning the company into a fast-growing global aesthetics business, which sold Huadong Medicine Company for £165 million. was sold in In 2018.
During his tenure he oversaw several successful capital raises and several strategic M&A transactions, including the disposal of non-core business to Alliance Pharma in 2015 for £132 million. Prior to Sinclair Pharma, Allen was the Group Financial Controller of Zenova Group and KS. Biomedics.
Neil Campbell, Chief Executive Officer of Inspiration Healthcare, said: “We are delighted to have someone of such caliber join Inspiration Healthcare. His track record of building and growing commercial healthcare businesses and his capital markets experience will be invaluable as we continue to execute our strategy and build a world leading innovative medical technology company focused on neonatal intensive care.
Incoming Chief Financial Officer Alan Olby said: “I am delighted to join Inspiration Healthcare at this exciting stage of the Group’s growth. The Group’s world-class design and manufacturing expertise enables it to provide a wide range of specialist, innovative products that meet critical needs within the global neonatal market and I look forward to working to accelerate the Group’s growth strategy. I am curious











